Want to see COCH full AI Analyst Report?

Envoy Medical (COCH) Price & Analysis

126 Followers

COCH Stock Chart & Stats

$0.66

>-$0.01(-1.13%)

At close: Jul 27 4:00 PM EDT

$0.66

>-$0.01(-1.13%)

Day’s Range― - ―

52-Week Range$0.36 - $1.89

Previous CloseN/A

Volume100.00

Average Volume (3M)394.38K

Market Cap

$52.19M

Enterprise Value$21.49

Total Cash (Recent Filing)$25.25M

Total Debt (Recent Filing)$889.00K

Price to Earnings (P/E)―

Beta0.22

Next Earnings

Aug 17, 2026

EPS Estimate

-0.08

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.02

Shares Outstanding76,881,110

10 Day Avg. Volume193,663

30 Day Avg. Volume394,378

Financial Highlights & Ratios

PEG Ratio0.03

Price to Book (P/B)-1.10

Price to Sales (P/S)53.77

P/FCF Ratio-0.70

Enterprise Value/Market Cap<0.01

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit>-0.01

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price Target

$2.25

Price Target Upside240.91% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)-0.29

Revenue Forecast (FY)$200.00K

Bulls Say, Bears Say

Bulls Say

Low Leverage And Positive Equity BaseA low debt-to-equity (~0.09) and a return to positive equity provide structural financial flexibility. This reduces short-term insolvency risk and preserves the company’s ability to access capital or invest in commercial scale-up without immediate debt servicing pressure, improving runway resilience.

Differentiated Fully Implanted Cochlear TechnologyA fully implanted cochlear system that eliminates external processors is a durable competitive advantage if commercialized: it addresses compliance/usability gaps versus traditional devices, can create a distinct clinical value proposition for surgeons and patients, and supports long-term market differentiation.

Management Ended ATM Equity ProgramEnding the at-the-market program signals management confidence and reduces near-term automatic dilution risk. That decision can stabilize investor perception around capital strategy and gives management tactical flexibility to time larger financings more strategically, aiding longer-term funding plans.

Bears Say

Large And Persistent Cash BurnSustained negative operating and free cash flow around -$20M TTM creates a structural funding requirement. Persistent burn forces recurring external financing, dilutes existing holders, and constrains ability to invest selectively; without durable revenue uptake, runway and execution risk remain elevated.

Minimal Revenue And Negative Gross ProfitVery low revenue and negative gross profit indicate current unit economics are unfavorable and product adoption is limited. Until manufacturing costs, pricing, reimbursement, or demand materially improve, the company lacks a sustainable path to margin expansion and profitable operations.

Ongoing Nasdaq Listing Compliance RiskA continuing bid-price deficiency and extended compliance timeline create a structural overhang. Potential remedies like reverse splits can affect liquidity and investor base, while the listing risk diverts management attention and may hamper access to broader capital markets until resolved.

Envoy Medical News

Envoy Medical initiated with a Buy at Lucid Capital

Lucid Capital analyst Alex Nowak initiated coverage of Envoy Medical (COCH) with a Buy rating and $2 price...

4d ago

COCH

Envoy Medical Ends ATM Equity Program Amid Capital Confidence

Envoy Medical ( ($COCH) ) has provided an update. Envoy Medical, Inc., a Nasdaq-listed hearing health company, develops...

1M ago

COCH

Envoy Medical signs multi-part series with New to The Street

Envoy Medical (COCH) has signed a multi-part national media series with New to The Street. The campaign is...

2M ago

COCH

Envoy Medical Granted Extension to Regain Nasdaq Compliance

Envoy Medical ( ($COCH) ) just unveiled an announcement. Envoy Medical, Inc. disclosed that on November 19, 2025,...

2M ago

COCH

Envoy Medical Shareholders Expand Equity and Governance Plans

Envoy Medical ( ($COCH) ) has provided an announcement. At its May 12, 2026 annual meeting, Envoy Medical...

2M ago

COCH

COCH Upcoming Earnings Report: What to Expect?

Envoy Medical, Inc. Class A (COCH) is scheduled to report 1st quarter earnings on 05/20/2026, before the market...

2M ago

COCH

Envoy Medical Flags Limited Risk Detail, Urges Investors to Review 2026 Form 10-K for Key Uncertainties

Envoy Medical, Inc. Class A (COCH) has disclosed a new risk, in the Regulation category. Envoy Medical, Inc....

3M ago

COCH

Envoy Medical initiated with a Buy at H.C. Wainwright

H.C. Wainwright initiated coverage of Envoy Medical (COCH) with a Buy rating and $2.50 price target Envoy is...

4M ago

COCH

Envoy Medical Regains Nasdaq Listing Compliance After Financing

Envoy Medical ( ($COCH) ) has issued an update. On February 24, 2026, Envoy Medical announced it had...

5M ago

COCH

Envoy Medical Closes Upsized Public Offering to Fund Growth

Envoy Medical ( ($COCH) ) just unveiled an announcement. On February 12, 2026, Envoy Medical announced the closing...

6M ago

COCH

Envoy Medical Grants Stock Options to Key Executives

Envoy Medical ( ($COCH) ) has provided an update. On February 5, 2026, Envoy Medical, Inc.’s compensation committee...

6M ago

COCH

Envoy Medical Extends Shortfall Warrants, Enhancing Capital Flexibility

The latest announcement is out from Envoy Medical ( ($COCH) ). On December 18, 2025, Envoy Medical, Inc....

7M ago

COCH

Envoy Medical files to sell Class A common stock, no amount given

17:22 EST Envoy Medical (COCH) files to sell Class A common stock, no amount given Published first on...

7M ago

COCH

Envoy Medical Updates Investors on Strategic Plans

Envoy Medical ( ($COCH) ) has shared an update. Envoy Medical has released an updated investor presentation detailing...

8M ago

COCH

COCH FAQ

What was Envoy Medical’s price range in the past 12 months?

Envoy Medical lowest stock price was $0.36 and its highest was $1.89 in the past 12 months.

What is Envoy Medical’s market cap?

Envoy Medical’s market cap is $52.19M.

When is Envoy Medical’s upcoming earnings report date?

Envoy Medical’s upcoming earnings report date is Aug 17, 2026 which is in 17 days.

How were Envoy Medical’s earnings last quarter?

Envoy Medical released its earnings results on May 11, 2026. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.14 by $0.06.

Is Envoy Medical overvalued?

According to Wall Street analysts Envoy Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Envoy Medical pay dividends?

Envoy Medical does not currently pay dividends.

What is Envoy Medical’s EPS estimate?

Envoy Medical’s EPS estimate is -0.08.

How many shares outstanding does Envoy Medical have?

Envoy Medical has 76,881,110 shares outstanding.

What happened to Envoy Medical’s price movement after its last earnings report?

Envoy Medical reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.14. Following the earnings report the stock price went down -0.155%.

Which hedge fund is a major shareholder of Envoy Medical?

Currently, no hedge funds are holding shares in COCH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Envoy Medical Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

187.16%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Envoy Medical

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.

Envoy Medical (COCH) Earnings & Revenues

Historic Earnings Reports

COCH Stock 12 Month Forecast

Average Price Target

$2.25

▲(240.91% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","2":"$2","3":"$3","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.79,0.9215384615384616,1.0530769230769232,1.1846153846153846,1.3161538461538462,1.4476923076923078,1.5792307692307692,1.7107692307692308,1.8423076923076924,1.973846153846154,2.1053846153846156,2.236923076923077,2.3684615384615384,{"y":2.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.79,0.9023076923076924,1.0146153846153847,1.126923076923077,1.2392307692307694,1.3515384615384616,1.4638461538461538,1.5761538461538462,1.6884615384615385,1.8007692307692307,1.9130769230769231,2.025384615384615,2.1376923076923076,{"y":2.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.79,0.8830769230769231,0.9761538461538461,1.0692307692307692,1.1623076923076923,1.2553846153846153,1.3484615384615384,1.4415384615384617,1.5346153846153845,1.6276923076923078,1.7207692307692306,1.8138461538461539,1.906923076923077,{"y":2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.49,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.445,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.29,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.773,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.805,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.81,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.661,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.649,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.699,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.705,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.681,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.7,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.79,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >